Innovation Pharmaceuticals Inc (IPIX)

[oddone33320]

" FDA approves The Medicines Co's acute skin infection drug


The U.S. Food and Drug Administration approved The Medicines Co's single-dose intravenous drug to treat acute bacterial skin infections, the agency's third approval for the same condition this year.

.....


The antibiotic received an expedited review by the FDA and was designated a qualified infectious disease product, qualifying it for an extra five years of marketing exclusivity.


Jefferies & Co analyst Biren Amin told Reuters he expects Orbactiv to be launched in the fourth quarter and estimated peak U.S. sales of $150 million by 2021. "

(http://news.yahoo.com/fda-approves-medicines-cos-acute-skin-infection-drug-222825203--finance.html)

Found that interesting. Expedited review/approval, single-dose, and only $150 million peak sales expected???

EDIT: OOPS, looks like I was late to report on this...